Form 4: Medifast CFO James P. Maloney Reports Stock Disposals for Tax Obligations

James P. Maloney, CFO of Medifast, Inc., reported the disposal of common stock to cover withholding tax obligations upon the vesting of restricted stock units.

Summary

• On March 15, 2024, James P. Maloney, the Chief Financial Officer of Medifast, Inc., disposed of shares of common stock to cover withholding tax obligations.
• A total of 73, 119, and 424 shares were disposed of at a price of $36.61 per share.
• These transactions were related to the vesting of restricted stock units.
• Following these transactions, Maloney beneficially owns 19,534 shares of Medifast common stock.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock disposals for tax purposes, and does not inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives. This filing indicates the CFO's disposal of shares to cover tax obligations related to vested stock, which is a common practice.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units (RSUs) that vest over time.
• Upon vesting, these RSUs are subject to income tax, and executives often sell a portion of the newly vested shares to cover these tax obligations.
• This practice is common across publicly traded companies and is not unique to Medifast.
• Comparable companies such as Herbalife Nutrition and Nu Skin Enterprises also see similar filings from their executives related to RSU vesting and tax-related stock disposals.

Key Dates